Anthony J. Dolisi

CEO, President & Chairman at Olaregen Therapeutix

Anthony has built a 25+ year career in progressive leadership roles. He is a results-driven executive with a track record of success driving rapid revenue growth in start-up and/or turn around business environments. Extensive experience in pharmaceutical, biotech, and molecular diagnostics markets and medical devices, with first-in-class product launches in Cardiology, CNS, Oncology, Virology, Wound Care and Infectious Disease by leveraging best practices in clinical, sales, and commercial operations. Anthony has developed peak-performing commercial teams that consistently maximize productivity and revenue generation. His experience is both broad and deep and includes: Launch Planning, P&L Management, Licensing & Co-Promotion, Team Leadership & Motivation, Brand/Consumer Marketing, Med-ED/KOL Development, Creative Market Segmentation, Managed Care/Contracting, Community/Patient Advocacy. His industry experience specializes in business leadership with fortune 500 companies including American Home Products, Glaxo SmithKline, Agouron, Pfizer, and Johnson & Johnson. Combining both commercial and clinical expertise, he has made his mark by building multi-million-dollar businesses, igniting growth in business lines, devising innovative differentiated product strategies, and spurring company growth through creative and comprehensive portfolio strategies. As President & CEO, Anthony is responsible for all the functional sectors of the Olaregen organization, driving the performance and success of the business. Anthony will lead in the efforts to commercialize products, overseeing all facets of the company’s go-to-market strategy as well as playing a vigorous role in pipeline development, acquisitions, and strategic alliances.

Timeline

  • CEO, President & Chairman

    Current role